Want to hire this expert for a project? Request a quote for free.
Profile Details
Subject Matter Expertise
Services
Work Experience
Postdoctoral Associate
University of Texas MD Anderson Cancer Center
March 2012 - Present
PhD Associate
Clark Atlanta University
January 2007 - December 2011
Education
PhD/ Molecular Biology (Biological Sciences)
Clark Atlanta University
January 2007 - December 2011
B.S. (Biological Sciences)
Clark Atlanta University
August 2001 - May 2005
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2017). AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers . Molecular Cancer Research. 15. (1). p. 45-58.
(2017). Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer . Oncotarget. 8. (9). p. 14897-14911.
(2016). PKCiota promotes ovarian tumor progression through deregulation of cyclin e . Oncogene. 35. (19). p. 2428-2440.
(2016). Targeting the Cell Cycle in Breast Cancer . Breast Diseases. 27. (4). p. 256-260.
(2015). Inhibitor of differentiation 4 (ID4): From development to cancer . Biochimica et Biophysica Acta - Reviews on Cancer. 1855. (1). p. 92-103.
(2013). Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells . Anticancer Research. 33. (10). p. 4271-4278.
(2009). Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer . BMC Cancer. 9.
(2007). Id1-, Id2-, and Id3-regulated gene expression in E2A positive or negative prostate cancer cells . Prostate. 67. (13). p. 1411-1420.